Shared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: A randomized control trial

Patient Educ Couns. 2020 Apr;103(4):702-708. doi: 10.1016/j.pec.2019.12.004. Epub 2019 Dec 11.

Abstract

Objective: To evaluate the effectiveness of a shared decision-making and patient engagement (SDM-PE) program concerning in-hospital stay during acute exacerbation of COPD and determine its impact on patients' perceived health status.

Methods: Patients were randomly allocated to a control group that received standard treatment or an intervention group that received an individualized SDM-PE program in addition to standard treatment. The SDM-PE program included personalized health care focused on information about the disease, healthcare management, and reinforcement of behaviors regarding nutrition and exercise taking into account patients' preferences.

Results: A comparative analysis between groups showed a significant improvement in perceived health status at discharge in patients included in the experimental group compared to those in the control group (60.28 ± 21.65 vs. 54.13 ± 22.69, p = 0.036). In addition, perceived health status, COPD knowledge, adherence to pharmacological treatment, general functionality, and healthy lifestyle measures were significantly better at 3-month follow-up in the intervention group.

Conclusion: An SDM-PE program significantly enhanced all the clinical measures assessed during hospitalization at 3-month follow-up.

Practice implications: COPD patients and professionals need to work together to select the best care and treatment model for patients, taking into account individual values and preferences.

Keywords: Chronic obstructive; Decision making; Hospital medicine; Patient participation; Pulmonary disease.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Decision Making
  • Decision Making, Shared
  • Hospitalization
  • Humans
  • Patient Participation*
  • Patient Preference
  • Pulmonary Disease, Chronic Obstructive* / therapy